X-TRIPP UT PH ILD and XeMRI MutiSite study Pro00118547 Assessing Acute Pharmacodynamics and Long-Term Response to Inhaled Prostacyclin with Hyperpolarized 129Xe MRI in patients with PH-ILD
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
October 17, 2025
End Date
September 24, 2030
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
October 17, 2025
End Date
September 24, 2030